Morning Hypertension and Monitoring of Metabolism
Latest Information Update: 24 Sep 2014
At a glance
- Drugs Telmisartan (Primary) ; Telmisartan/hydrochlorothiazide (Primary)
- Indications Essential hypertension
- Focus Adverse reactions; Therapeutic Use
- Sponsors Boehringer Ingelheim
- 24 Sep 2014 New trial record